FDA 483 - Indiana Botanic Gardens, Inc - September 30, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Indiana Botanic Gardens, Inc. in Hobart, IN, an OTC drug manufacturer, was cited with two observations during an FDA inspection. The inspection revealed deficiencies in following written production and process control procedures, specifically concerning inconsistent mixing times for an OTC product without proper validation. Additionally, the firm failed to store drug products under appropriate conditions, leading to inadequate segregation of expired and cosmetic products from those undergoing stability testing.
- Office
- Detroit District Office
- Person
ID · d5b1c3cb-9500-41d7-b577-da7060cd781e